Beyond Type (commonly known as Beyond Type 1) is a global nonprofit that supports people living with diabetes through education, advocacy, community programs and grants; it is not an investment firm or a for‑profit portfolio company[4].[1]
High‑Level Overview
- Beyond Type 1 is a nonprofit whose mission is to change what it means to live with diabetes by uniting the global diabetes community and providing resources, education, advocacy and support for people with Type 1 and Type 2 diabetes[4].[1]
- Core focus areas include public education and peer support, advocacy for access to insulin and diabetes care (e.g., GetInsulin), community programs (Beyond Diagnosis, Beyond Scholars, Beyond Type Run), and innovation grants to support diabetes solutions[4].[2]
- The organization serves people with diabetes and their families worldwide, offering digital resources, private community groups, scholarship and grant programs, and publicity/advocacy campaigns aimed at improving access and reducing stigma[4].[6]
- Impact on the startup/health ecosystem: Beyond Type 1 acts as a community and advocacy hub that channels patient voice, funds early-stage diabetes‑focused social and digital programs through Innovation Grants, and raises visibility for access issues that can influence policy and market priorities in diabetes care[6].[4]
Origin Story
- Founding year and founding context: Beyond Type 1 was founded in 2015 and has grown into a large digital diabetes community (reported as serving more than two million people in some descriptions)[2][7].
- Leadership & evolution: The organization began as a community-driven initiative leveraging social media and technology to support people with Type 1 diabetes and has since expanded programs to include Type 2 resources, international advocacy, scholarship programs, running fundraising teams, and grants supporting mobile health and access work[1][4][6].
- Early traction / pivotal moments: The group’s rapid digital growth, creation of signature programs (e.g., GetInsulin.org, Beyond Type Run), and public campaigns have raised its profile; in 2025 it marked its 10th anniversary and launched a refreshed website and a “next phase” of community impact programming[1][7].
Core Differentiators
- Community scale and digital reach: A large, active online community and private peer groups that provide 24/7 community support and lived‑experience content[2][4].
- Patient‑centered advocacy: Programs like GetInsulin and global advocacy roles emphasize access and equity rather than commercial product marketing[2][6].
- Program breadth: Combines education (Beyond Diagnosis), scholarships (Beyond Scholars), grants for innovation, and fundraising/engagement through events like Beyond Type Run[4][6].
- Partnerships & credibility: Works with global health networks (e.g., NCD Alliance) and funds/partners with other diabetes nonprofits and research organizations to amplify impact[6][5].
Role in the Broader Tech & Health Landscape
- Trend alignment: Rides the digital health, patient‑empowerment and community‑driven advocacy trends by using online platforms and social media to scale support and influence care access conversations[4][1].
- Timing: As diabetes technology (CGMs, pumps, telehealth) and affordability/access debates intensify globally, a community organization that centers lived experience and access advocacy can accelerate policy change and user adoption of beneficial technologies[2][4].
- Market forces in their favor: Growing public attention to insulin pricing, broader adoption of digital health tools, and funders interested in health equity increase the relevance of Beyond Type 1’s programs and grants[2][6].
- Influence: Beyond Type 1 helps shape the narrative and priorities for patient needs, which can influence product design priorities for startups and policy for payers and regulators[6].
Quick Take & Future Outlook
- What’s next: Continued international expansion of advocacy and health equity work, scaling of innovation grants (with a 2025 focus on mobile health), and broader programming as the organization marks its first decade of operation[1][6].
- Trends to watch: Global insulin access campaigns, digital diabetes self‑management tools, and partnerships between nonprofits and diabetes tech startups will shape Beyond Type 1’s influence and opportunities for collaboration[2][6].
- How influence may evolve: By maintaining strong patient voice and grantmaking, Beyond Type 1 can remain a key bridge between people living with diabetes, researchers, startups and policy makers—shaping product priorities and access initiatives.
If you want, I can:
- Convert this into a one‑page investor/partner brief or a slide‑ready summary.
- Pull key leadership names, latest financials or grant recipients (GuideStar/IRS filings) for due diligence.
